CPDR Patient Education Program
Central to the CPDR Patient Education Program is the educational and counseling services provided to patients and their families by the Patient Educator, Jane Hudak, RN, PhD. At the Multi-disciplinary Prostate Cancer Clinic, she provides newly diagnosed prostate cancer patients and their families with invaluable information essential to understanding their disease and making an informed decision about their cancer treatment as well as emotional support to facilitate their adjustment to their cancer diagnosis.
The Patient Educator also provides extensive (4-5 hour) individual, couple or small-group preoperative counseling sessions for patients (and their families) scheduled to undergo a radical retropubic prostatectomy or robotic-assisted laparoscopic prostatectomy. These comprehensive sessions coach the patient and their families through the preoperative and postoperative phases of the surgery thereby facilitating their surgical recovery as well as emotional recovery. The counseling sessions are also another venue in which participation in research studies at CPDR is addressed. Another vital component of the Patient Education Program for prostatectomy patients is the Battle Buddy Program initiated in 2006. This program matches patients scheduled for a prostatectomy with "veteran" prostatectomy patients who volunteer to contact the new patient throughout their surgical experience to provide guidance and support as needed. CPDR has about 50 volunteer Battle Buddies. Approximately fifty percent of our prostatectomy patients each year (40-50) choose to be involved in the Battle Buddy Program.
The Patient Educator also provides individualized educational and counseling services to patients in the Prostate Cancer Recurrence Clinic. She provides the patients and their families with information about the various treatment options and resources with which to make an informed treatment decision as well as resources to help them cope with their progressing disease and the opportunities to participate in clinical research studies.
August 21, 2014
ERG Monoclonal Antibody [9FY] Patent Issued To The Uniformed Services University Of The Health Sciences Center For Prostate Disease Research & Biocare Medical
Concord, CA – The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. has been awarded a patent in the United States (Patent No: US 8,765,916 B2) and Europe for ERG monoclonal antibodies. The patent is pending in Australia, Canada and Japan. ERG mouse antibody 9FY is a rigorously characterized antibody for its specificity of the ERG protein detection among the closely related members of the ETS transcription factor family in biological specimens.
Read Full Article
August 6, 2014
Genomic Health Announces Positive Topline Results of Additional, Large Independent Validation Study of Oncotype DX® Prostate Cancer Test with Multiple Clinical Endpoints
Redwood City, CA – PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced positive preliminary results from an additional independent clinical validation study conducted by the Center for Prostate Disease Research (CPDR) demonstrating that the Oncotype DX® Genomic Prostate Score (GPS) predicts multiple clinical endpoints related to disease aggressiveness in men with low- and intermediate-risk prostate cancer. This study validated the Oncotype DX prostate cancer test as a ...
Read Full Article
WRNMMC UsToo! Newsletter
Read the AUGUST 2014 Newsletter